Prognostic factors for long-term outcomes in relapsing-remitting multiple sclerosis: exploratory analysis of 15-year data from the PRISMS study

被引：0
|
作者：
Kappos, L.
Uitdehaag, B.
Kuhle, J.
Issard, D.
Casset-Semanaz, F.
机构：
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[3] Cytel Inc, Geneva, Switzerland
[4] Merck Serono SA, Geneva, Switzerland
来源：
JOURNAL OF NEUROLOGY | 2013年 / 260卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O232
引用
收藏
页码：S14 / S15
页数：2
相关论文
共 50 条
  • [1] Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15
    Kappos, Ludwig
    Kuhle, Jens
    Multanen, Juha
    Kremenchutzky, Marcelo
    di Cantogno, Elisabetta Verdun
    Cornelisse, Peter
    Lehr, Lorenz
    Casset-Semanaz, Florence
    Issard, Delphine
    Uitdehaag, Bernard M. J.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11): : 1202 - 1207
  • [2] Measures of Early Clinical Activity as Prognostic Factors for Long-Term Clinical Outcomes in Relapsing-Remitting Multiple Sclerosis
    Traboulsee, Anthony
    Uitdehaag, Bernard M. J.
    Kappos, Ludwig
    Sandberg-Wollheim, Magnhild
    Li, David
    Jongen, Peter
    Constantinescu, Cris C.
    Verdun, Elisabetta
    Cornelisse, Peter
    [J]. NEUROLOGY, 2010, 74 (09) : A100 - A100
  • [3] Long-term safety and tolerability of interferon β-1a in relapsing-remitting multiple sclerosis (RRMS):: Four-year data from the PRISMS study
    Rieckmann, P
    Gold, R
    [J]. NEUROLOGY, 2001, 56 (08) : A354 - A354
  • [4] Relation of long-term exposure to subcutaneous interferon-β-1a with clinical outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS-15 study
    Kappos, L.
    Cornelisse, P.
    Lehr, L.
    Kuhle, J.
    Uitdehaag, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 39 - 39
  • [5] Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
    Bsteh, Gabriel
    Ehling, Rainer
    Lutterotti, Andreas
    Hegen, Harald
    Di Pauli, Franziska
    Auer, Michael
    Deisenhammer, Florian
    Reindl, Markus
    Berger, Thomas
    [J]. PLOS ONE, 2016, 11 (07):
  • [6] Baseline predictors of mortality in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS-15 study
    Cornelisse, P.
    Lehr, L.
    Baldinetti, F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 222 - 222
  • [7] Improved Quality of Life in Patients with Relapsing-Remitting Multiple Sclerosis on Long-Term Intramuscular Interferon Beta-1a: A 15-Year Study
    Weinstock-Guttman, Bianca
    Bermel, Robert
    Bourdette, Dennis
    Foulds, Pamela
    You, Phil
    Rudick, Richard
    [J]. NEUROLOGY, 2009, 72 (11) : A238 - A239
  • [8] Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis
    Kalincik, Tomas
    Diouf, Ibrahima
    Malpas, Charles
    Horakova, Dana
    Havrdova, Eva
    Trojano, Maria
    Ayuso, Guillermo Izquierdo
    Eichau, Sara
    Onofrj, Marco
    Lugaresi, Alessandra
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Grand'Maison, Francois
    Sola, Patrizia
    Ferraro, Diana
    Shaygannejad, Vahid
    Alroughani, Raed
    Hupperts, R. M. M.
    Terzi, Murat
    Boz, Cavit
    Lechner-Scott, Jeannette
    Cartechini, Elisabetta
    Van Pesch, Vincent
    Iuliano, Gerardo
    Granella, Franco
    Bergamaschi, Roberto
    Fernandez Bolanos, Ricardo
    Spitaleri, Daniele Litterio A.
    Slee, Mark
    Vucic, Ostoja
    Ampapa, Radek
    McCombe, Pamela
    Ramo-Tello, Cristina
    Petersen, Thor
    Verheul, Freek
    Prevost, Julie
    Olascoaga Urtaza, Francisco Javier
    Cristiano, Edgardo
    Butzkueven, Helmut
    [J]. NEUROLOGY, 2020, 94 (15)
  • [9] Long-term outcome of minocycline in relapsing-remitting multiple sclerosis
    Zhang, Y.
    Metz, L. M.
    Yong, V. W.
    Bell, R. B.
    Yeung, M.
    Patry, D.
    Mitchel, J. R.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 (09): : 1226 - 1226
  • [10] The long-term safety and tolerability of high-dose interferon β-1a in relapsing-remitting multiple sclerosis:: 4-year data from the PRISMS study
    Gold, R
    Rieckmann, P
    Chang, P
    Abdalla, J
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (08) : 649 - 656
12345